MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
261.44
+4.96
+1.93%
After Hours: 261.15 -0.29 -0.11% 19:59 10/09 EDT
OPEN
255.09
PREV CLOSE
256.48
HIGH
261.61
LOW
254.99
VOLUME
5.73M
TURNOVER
--
52 WEEK HIGH
281.07
52 WEEK LOW
178.91
MARKET CAP
630.04B
P/E (TTM)
30.31
1D
5D
1M
3M
1Y
5Y
1D
NIH makes big bet on public-private partnership over cancer vaccines, NYT says
TipRanks · 10h ago
Midday Fly By: SpaceX buys spectrum, Delta cuts earnings guidance
TipRanks · 12h ago
Johnson & Johnson says long-term data boosts Icotyde for plaque psoriasis
Seeking Alpha · 12h ago
Reported Earlier: 'Cancer Vaccines Are the N.I.H's Next Big Bet' - The New York Times
Benzinga · 13h ago
Looking for Dividend Aristocrats? These 3 Healthcare Stocks Deserve a Closer Look
TipRanks · 13h ago
Cancer Stocks to Consider as Oncology Innovation Accelerates
NASDAQ · 14h ago
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), United Therapeutics (UTHR) and Ionis Pharmaceuticals (IONS)
TipRanks · 14h ago
Johnson & Johnson Reports Sustained Two-Year ICOTYDE Results In Plaque Psoriasis
NASDAQ · 16h ago
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. Its segments include Innovative Medicine and MedTech. The Innovative Medicine segment focuses on various therapeutic areas, oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases and cardiovascular and metabolism. Its products include CARVYKTI (ciltacabtagene autoleucel), DARZALEX (daratumumab), DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), ERLEADA (apalutamide), among others. The MedTech segment develops and manufactures a broad portfolio of products used in cardiovascular, orthopedics, surgery, and vision supporting physicians, hospitals, eye care professionals and healthcare systems across a range of acute and elective procedures. The Cardiovascular portfolio includes electrophysiology products. It is also focused on proprietary Firelink degrader antibody conjugate platform.

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.